Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
The method involves detailed molecular simulations of the receptor in its native membrane environment, with ensemble virtual screening focusing on its conformational mobility. When dealing with dimeric or oligomeric receptors, the whole functional complex is modelled, and the tentative binding pockets on and between the subunits are established to address all possible mechanisms of action.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q14416
UPID:
GRM2_HUMAN
Alternative names:
-
Alternative UPACC:
Q14416; B0M0K7; Q14CU5; Q52MC6; Q9H3N6
Background:
Metabotropic glutamate receptor 2 (mGluR2) is a crucial component in the central nervous system, acting as a G-protein coupled receptor for glutamate. This receptor plays a pivotal role in modulating neurotransmission through its ability to inhibit adenylate cyclase activity upon activation by its ligand, glutamate. Its involvement in synaptogenesis and synaptic stabilization highlights its importance in neural communication and plasticity.
Therapeutic significance:
Understanding the role of Metabotropic glutamate receptor 2 could open doors to potential therapeutic strategies. Its regulatory function in neurotransmission and synaptic activities positions it as a key target for addressing neurological disorders.